NDC 63833-829

HAEGARDA C1 Esterase Inhibitor Subcutaneous (Human)

Human C1-esterase Inhibitor

HAEGARDA C1 Esterase Inhibitor Subcutaneous (Human) is a Kit in the Plasma Derivative category. It is labeled and distributed by Csl Behring Gmbh. The primary component is .

• Product ID: 63833-829_79516135-ba14-41c9-bb9a-6938cfd297ff
• NDC: 63833-829
• Product Type: Plasma Derivative
• Proprietary Name: HAEGARDA C1 Esterase Inhibitor Subcutaneous (Human)
• Generic Name: Human C1-esterase Inhibitor
• Dosage Form: Kit
• Marketing Start Date: 2017-06-22
• Marketing Category: BLA / BLA
• Application Number: BLA125606
• Labeler Name: CSL Behring GmbH
• Active Ingredient Strength: 0
• NDC Exclude Flag: N
• Listing Certified Through: 2021-12-31

Packaging

NDC 63833-829-02

1 KIT in 1 CARTON (63833-829-02) * 6 mL in 1 VIAL, SINGLE-USE (63833-839-01) * 6 mL in 1 VIAL, SINGLE-USE (63833-765-19)

• Marketing Start Date: 2017-06-22
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 63833-829-02 [63833082902]

HAEGARDA C1 Esterase Inhibitor Subcutaneous (human) KIT

• Marketing Category: BLA
• Application Number: BLA125606
• Product Type: PLASMA DERIVATIVE
• Billing Unit: EA
• Marketing Start Date: 2017-06-22

Drug Details

NDC Crossover Matching brand name "HAEGARDA C1 Esterase Inhibitor Subcutaneous (Human)" or generic name "Human C1-esterase Inhibitor"

NDC	Brand Name	Generic Name
63833-825	Berinert	HUMAN C1-ESTERASE INHIBITOR
42227-081	Cinryze	HUMAN C1-ESTERASE INHIBITOR
42227-083	Cinryze	HUMAN C1-ESTERASE INHIBITOR
63833-828	HAEGARDA	HUMAN C1-ESTERASE INHIBITOR
63833-829	HAEGARDA	HUMAN C1-ESTERASE INHIBITOR